Using flavoxate as primary medication for patients suffering from urge symptomatology

International Urogynecology Journal

Volumn 10, Issue 2, 1999, Pages 91-95

  Fehrmann Zumpe, P ^a,c   Karbe, K ^a   Blessman, G ^b  

^a Sanofi Winthrop ^*

^b Sanofi Winthrop   (Germany)

^c NONE   (Germany)

Author keywords

Flavoxate; Incontinence; Residual urine; Urge

Indexed keywords

FLAVOXATE;

ADULT; AGED; ARTICLE; BLADDER CAPACITY; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERANCE; DYSURIA; EDEMA; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NOCTURIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RESIDUAL URINE; TACHYCARDIA; URGE INCONTINENCE; URTICARIA; VERTIGO; VOMITING; XEROSTOMIA;

EID: 0032939435     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00004018     Document Type: Article

References (14)

1. Graziani G, Cazzulani P, Panzarasa R (eds) Flavoxate. Geneva: Bioscience Ediprint, 1983:7-19
2. Graziani G, Cazzulani P, Panzarasa R (eds) Flavoxate. Geneva: Bioscience Ediprint, 1983:20-23
3. Kaseda M et al. Effects of flavoxate hydrochloride on bladder function in the rat. Clin Physiol 1975;5:11
4. Gaudenz R, Weil A. Motor urge incontinence: diagnosis and treatment. Urol Int 1980;35:1
5. Herbst WP. Double blind comparison of flavoxate and propantheline as urologic antispasmodics. AJCR 1970;1:65
6. Ruffmann R, Sartani A. Flavoxat, ein Spasmolytikum relaxierender Wirkung auf glatte Muskulatur. Drugs Exp Clin Res 1987;XIII:57-62
7. Tajana A, Cova A. Current status of knowledge on flavoxate pharmacokinetics. Flavoxate workshop Cernobbio 29.09.1981, Cornelli U, Graziani G. Geneva: Bioscience Ediprint, 1983;33-52
8. Milani R, Scalambrino S, Milia R et al. Double-blind crossover comparison of flavoxate and oxybutynin in women affected by urinary urge syndrome. Int Urogynecol J 1993;4:3-8
9. Delaere KPJ, Michiels HGE, Debruyne FMJ, Moonen WA. Flavoxate hydrochlorid in the treatment of detrusor instability. Urol Int 1977;32:377-381
10. Stanton SLA. A comparison of emepronium bromide and flavoxate hydrochloride in the treatment of urinary incontinence. J Urol 1973;110:529
11. Wehnert J, Sage S. Vergleichende Untersuchungen zur Wirkung von Mictonorm (Propiverin hydrochlorid) und Spasuret® 200 (Flavoxat hydrochlorid) auf den Detrusor vesicae. Zeitschr Urol Nephrol 1989;82:259-263
12. Jonas U, Petri E, Kissel J. Effect of flavoxate on hyperactive detrusor muscle. Eur Urol 1979;5:106-109
13. Milani R, Scalambrino S, Carrera S, Pezzoli P, Ruffmann R. Comparison of flavoxate hydrochloride in daily dosages of 600 versus 200 mg for treatment of urgency and urge incontinence. J Int Med Res 1988;16:244-248
14. Vergani L, Le Piane U, Matthey L. Esperienza clinica su di un farmaco ad azione miotropa specifica per le basse vie urinarie nell'azione. Giorn Geront 1977;25:804